Skip to Content


PDF options:  View Fullscreen   Download PDF

PDF Transcript

For dental use.
Colgate Duraphat Rinse® is used for the prevention of dental caries (tooth decay). This mouth
wash contains fluoride as sodium salt, which belongs to a group of medicines called caries
preventing agents. Fluoride works in three ways.


No Fluoride + Fluoride

Sodium Fluoride Ph. Eur. 0.2% w/w
• An aid in the prevention of
dental caries
• Clinically proven to treat early
decay and prevent cavities
• Mint Flavour


3. Promotes
of early decay.

Do not use if you are allergic to sodium fluoride or any of the other ingredients. Do not use
under 6 years of age. Do not swallow. This mouth wash contains Benzoic Acid and Sodium
Benzoate, that are mildly irritant to the skin, eyes and mucous membrane.
Directions for use: Rinse once weekly with 5-10 ml (1-2 teaspoonfuls) around and between
the teeth for one minute and spit out. Do not swallow. Avoid drinking, eating or rinsing mouth
for 15 minutes after use. Do not exceed the stated dose. Excess dosage may cause nausea
and, in children under 12, dental fluorosis (discolouration of the teeth). If you have any further
questions on the use of this product, ask your dentist or pharmacist. You should not suffer any
side effects if used correctly, however if you notice anything unusual contact your dentist or
pharmacist. Keep out of the reach and sight of children. Do not use after the expiry date.
Active Substance: 0.2% w/w Sodium Fluoride Ph. Eur. 1 ml Colgate Duraphat Rinse®
contains 0.90 mg fluoride.
Other ingredients: Sodium Saccharin, Glycerol, Benzoic Acid, Sodium Benzoate, Pluronic
F108, Purified Water, Ethyl Alcohol 4.96%, Flavour, E133.
Colgate Duraphat Rinse® is a mint flavoured mouth wash. This bottle contains 150 ml.
Marketing Authorisation Holder: Colgate-Palmolive (UK) Ltd - Guildford Business Park Middleton Road - Guildford - Surrey - GU2 8JZ
Manufacturer: Thépenier Pharma Industrie Route d'Alençon - Saint-Langis-les-Mortagne F-61400 Mortagne - FRANCE
Last revised November 2007
PL 00049/0019 GSL 50130-04

Use by


2. Prevents mineral
loss caused by
plaque acids.

Batch n°


1. Reduces
the formation
of plaque acids.

+ Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.